Navigation Links
Covington Advises Actelion in Acquisition of Ceptaris Therapeutics
Date:7/31/2013

WASHINGTON, July 31, 2013 /PRNewswire-USNewswire/ -- Covington & Burling is advising Actelion Ltd on the acquisition of Ceptaris Therapeutics, Inc. The merger is contingent upon U.S. Food and Drug Administration approval of the Ceptaris product, VALCHLOR.

(Logo: http://photos.prnewswire.com/prnh/20120423/CL92331LOGO)

Under the terms of the merger agreement, Actelion's subsidiary, Actelion US Holdings Company, will pay Ceptaris $25 million upon signing the agreement and $225 million to Ceptaris' shareholders upon closing of the transaction. Ceptaris' shareholders are also eligible to receive additional payments based on net sales of VALCHLOR and/or the achievement of certain commercial milestones.

Actelion Ltd is a biopharmaceutical company headquartered in Switzerland. Founded in 1997, Actelion is a leading player in innovative science related to the endothelium - the single layer of cells separating every blood vessel from the blood stream. Ceptaris Therapeutics Inc. is a privately held, specialty pharmaceutical company that was established to develop a proprietary gel formulation of mechlorethamine hydrochloride for the treatment of early stage mycosis fungoides, a type of CTCL.

The corporate team was led by partners John Hurvitz and Stephen Infante, with associate Sara Needles.  

Covington & Burling LLP, an international law firm, provides corporate, litigation, and regulatory expertise to enable clients to achieve their goals.  Founded in 1919, the firm has more than 800 lawyers and offices in Beijing, Brussels, London, New York, San Diego, San Francisco, Seoul, Shanghai, Silicon Valley, and Washington, DC.

Contact: An Pham
+1.202.662.6575
apham@cov.com


'/>"/>
SOURCE Covington & Burling LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Covington Advises Omthera Pharmaceuticals on Merger with AstraZeneca
2. Positron Retains Investment Banking Firm Covington Associates To Lead Financing Of Cyclotron Project
3. Intrepid Investment Bankers LLC Advises Newport Medical Instruments, Inc. in its Sale to Covidien plc
4. Apex BioStrategists Advises On Flow Cytometry Sale To Coulter
5. Intrepid Investment Bankers LLC Advises A-Med Health Care in the Sale of its Specialty Pharmacy Assets to Modern HC Pharmacy, Inc., a portfolio company of Altamont Capital Partners
6. Underage Kids Get Hydrocodone Drugs Easily from Family & Friends, Advises New York Center for Living
7. Addressing Hearing Loss Proves Win-Win for Both Employer and Employee, BHI Advises During National Employee Wellness Month
8. Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises
9. CLUB DRUG CAUTIONARY: Dr. Jill Backfield, Addiction Specialist & Executive Director of New York Center for Living, Advises Parents of New Dangers of Mixing Marijuana & "Molly" (MDMA)
10. ConvaTec Announces Acquisition of AbViser Medical, LLC
11. Aperture Health, Inc. focuses in on IV Therapy Value Creation and the Merger and Acquisition Activities in the Home Infusion Therapy Sector.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2019)... ... July 12, 2019 , ... Autism is ... socialize with others. Given how widespread autism is (approximately 1 in 59 people ... cannot be “cured,” there are treatment options to teach children with autism methods ...
(Date:7/11/2019)... , ... July 11, 2019 , ... ... and Johnson and Nu Skin, and considered by a luminary of the cosmetic ... and organic oil consists of Sciadonic Acid DELTA-5, derived from exotic conifer seeds. ...
(Date:7/11/2019)... ... July 11, 2019 , ... Healthy Hemp Oil, a ... with TSA guidelines for domestic airline flights. , Previously, all forms of ... guidelines to allow some forms of cannabinoid (CBD) oil and FDA-approved ...
Breaking Medicine Technology:
(Date:7/13/2019)... ... July 14, 2019 , ... Dr. Rupa Jolly, dentist and wife ... Orleans Advocate's A-List of Most Influential New Orleanians in 2019. She joins more than ... newsmakers that have made an impact on the New Orleans community. , Combining their ...
(Date:7/13/2019)... ... July 12, 2019 , ... ... and CUBIO Innovation Center , sponsored by Hangzhou Investment Promotion Bureau, Fox ... June 2, 2019. , The conference attracted Fosun Pharmaceuticals, WuXi Biologics, Kelun Pharmaceutical, ...
(Date:7/11/2019)... , ... July 11, 2019 , ... ... knowledge tools and educational resources with a range of features to further advance ... the global pharmaceutical industry in manufacturing quality medicines for patients worldwide. The latest ...
(Date:7/10/2019)... ... 10, 2019 , ... Given that fertility treatment outcomes are ... remains committed to its core mission of fertility education and spreading awareness about ... will host six in-person seminars and three virtual webinars on topics ranging from ...
(Date:7/9/2019)... ... 2019 , ... Leading healthcare digital transformation platform provider, ... – Clinical Research Innovation (AACI-CRI) annual meeting, held in Chicago, to discuss strategies ... the leading provider of clinical research technology solutions, Forte continues to expand its ...
Breaking Medicine News(10 mins):